US health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk than previously thought. The move from the Food and Drug Administration Wednesday applies to all prescription and over-the-counter versions of ranitidine, best known by the brand… Continue reading at New York Post
RELATED ARTICLESMORE FROM AUTHOR
‘Everything Is a Story’ Inside Wyrmwood Gaming’s Narcissistic Funhouse
“Can’t I just say what happened?” A tall man in a flat cap asks, looking around the sparse meeting room. “Isn’t truth an absolute defense?” This is Doug Costello, the CEO of Wyrmwood Gaming. “It is,” says head of HR Bas Antoine, “if you have the whole story.” The two...
Tal Bachman: The Latest Emails Between God and Me
Tal and God continue their correspondence... ...